Inventor · disambiguated record
Elvire Gouze
Also filed as: GOUZE ELVIRE
6 granted patents·7 pending applications·12 citations·filing 2007–2021
77Inventor score
Files withINST NAT SANTE RECH MED5PFIZER4THERACHON2INSERM INST NAT DE LA SANTÉ ET DE LA RECH MÉDICALE1UNIV FLORIDA1
Top patents by PatentIndex Score
13 records- 0185US11021528B2Soluble fibroblast growth factor receptor 3 (SFGFR3) polypeptides and uses thereofPFIZER·Filed 2019·Granted Jun 1, 2021·3 cites·19 claims
- 0284US10724014B2Soluble fibroblast growth factor receptor 3 (FGR3) polypeptide for use in the prevention or treatment of skeletal growth retardation disordersINST NAT SANTE RECH MED·Filed 2014·Granted Jul 28, 2020·4 cites·14 claims
- 0383US10294289B2Soluble fibroblast growth factor receptor 3 (SFGFR3) polypeptides and uses thereofTHERACHON·Filed 2018·Granted May 21, 2019·5 cites·21 claims
- 0471US11814654B2Soluble fibroblast growth factor receptor 3 (FGR3) polypeptide for use in the prevention or treatment of skeletal growth retardation disordersINST NAT SANTE RECH MED·Filed 2020·Granted Nov 14, 2023·0 cites·11 claims
- 0570US11702642B2Soluble fibroblast growth factor receptor 3 (FGR3) polypeptide for use in the prevention or treatment of skeletal growth retardation disordersINST NAT SANTE RECH MED·Filed 2020·Granted Jul 18, 2023·0 cites·11 claims
- 0669US11697678B2Soluble fibroblast growth factor receptor 3 (SFGFR3) polypeptides and uses thereofPFIZER·Filed 2021·Granted Jul 11, 2023·0 cites·19 claims
- 0767US2020199545A1Soluble fibroblast growth factor receptor 3 (fgr3) polypeptide for use in the prevention or treatment of skeletal growth retardation disordersINST NAT SANTE RECH MED·Filed 2019·Application pending·0 cites
- 0855US2008187576A1Methods for treating articular disease or dysfunction using self-complimentary adeno-associated viral vectorsUNIV FLORIDA·Filed 2007·Application pending·0 cites
- 0954US2015344855A1A Soluble Fibroblast Growth Factor Receptor 3 (FGR3) Polypeptide For Use In The Prevention Or Treatment Of Skeletal Growth Retardation DisordersINSERM INST NAT DE LA SANTÉ ET DE LA RECH MÉDICALE·Filed 2013·Application pending·0 cites
- 1052US2021009657A1Soluble fgfr3 decoys for treating skeletal growth disordersPFIZER·Filed 2020·Application pending·0 cites
- 1149US2022290131A1Hybrid promoters and their uses in therapy, notably for treating type ii collagenopathiesINST NAT SANTE RECH MED·Filed 2019·Application pending·0 cites
- 1244US2020297799A1Treatment of abnormal visceral fat deposition using soluble fibroblast growth factor receptor 3 (sfgfr3) polypeptidesPFIZER·Filed 2018·Application pending·0 cites
- 1334US2018148494A1Soluble fgfr3 decoys for treating skeletal growth disordersTHERACHON·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Elvire Gouze files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →